China’s Great Wall of Opportunity has become easier to scale

By Scott Haughton, Envestors,

Just because China is the world’s second-largest economy and it is experiencing unprecedented growth in spending power, does not make it an easy market to penetrate. There are cultural attitudes and government roadblocks to overcome. But there are fantastic opportunities, particularly for businesses operating in cleantech, biotech and medtech sectors.

Let us look at an example to show what can be achieved. 

Biotech company ANCON Technologies saw the opportunities early on, and currently their ground-breaking AI and machine learning is part of a system to screen and diagnose COVID-19 through a non-invasive breath test.

“There are many Volatile Organic Compounds in your breath so each of your health conditions has a signature or a combination of VOCs, which we call biomarkers. Our research shows there are over 400 diseases that already have their own unique biomarkers. And it’s definitely an easier detection tool for the patient since it’s non-invasive,” explains Bing Tian, Director of Far East Development for ANCON Technologies.

For ANCON, China is both a rollout market and an invaluable partner in completing their research on how biomarkers can be used to detect COVID and a number of other diseases. Efforts to reach this point started a few years ago.

In 2017, ANCON joined the Envestors’ China programme, which included participation in exploratory road trips in China and inclusion in several technology competitions in the biggest cities in China. 

The same year, ANCON took part in the Envestors One Belt, One Roadshow, putting them in front of crucial strategic investors. These included listed corporates, leading venture capital firms and government backed technology transfer investment organisations. ANCON won the China-UK Innovation and Entrepreneurship Competition, held in Chengdu, an event that brought 3,000 projects and 70,000 participants in front of 450 experts.

The Envestors-ANCON collaboration has been going strong since then. In 2020, ANCON was a semifinalist in the Global Internet Competition “Straight to Wuzhen.” The World Internet Conference is hosted annually by the Cyberspace Administration of China and Zhejiang Provincial People’s Government.

Taking part in the 2020 contest has opened a lot of doors for the company. They’ve been able to meet potential partners and secure introductions to local players.

“The biggest help you can get from participating in competitions in China is getting the right introductions. Whatever your product is, you’ll get a chance to be introduced to local experts to help you set up in China,” says Bing Tian.

Exposure to strategic partners has already secured ANCON a local distribution partner in China. Due to the need for rollout in a large market, the partnership could be vital to the company’s work on COVID detection.

“Before COVID-19, our main target was lung cancer. When the pandemic hit, the first thing we did was try to get a biomarker profile of this new disease. That requires, first of all, that we collect as much data as possible and then have our AI build up the profile as quickly as possible.

We could potentially target over 400 diseases. For each one we need get the correct amount of data. China’s always your first target because it has the biggest population and, as the health care system in China is getting better and better, it’s getting easier to track specific patients’ data,“ Bing Tian notes.

Transparency of government procedure is one of the main concerns for companies looking to expand to China. However, the country is aiming to attract foreign startups through a number of government-funded programs.

Municipalities like Shanghai and Guangzhou are competing with each other to create opportunities for foreign companies, and Bing Tian says, “What I see is really just the amount of opportunities there. And you can see how the local government is willing to get foreign tech companies like us involved. They’re offering grants, funds and tax relief.” 

Success in China does not come without a great deal of effort and planning, but the potential rewards for UK companies accepting the challenge are huge, particularly if they deal in technology that will be of benefit to the advancement of China. Seeking a partner with experience in successfully securing strategic Chinese investment and M&A partners is a proven successful strategy.


Scott Haughton is from Envestors. Envestors’ digital investment platform brings together entrepreneurs and investors across geographies, communities and sectors – creating the single marketplace for early-stage investment in the UK.

Envestors partners with accelerators, incubators and angel networks to provide a white-label platform empowering them to promote deals, engage investors and connect to other networks.

Founded in 2004, Envestors has helped more than 200 high growth businesses raise more than £100m through its own private investment club.

Envestors is authorised and regulated by the Financial Conduct Authority.



Twitter: @EnvestorsLondon

Photo by Tom Fisk from Pexels

More from Family Friendly Working
Family food: Pear and Walnut Loaf
What would life be without the occasional cake? The Stem & Glory...
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *


This site uses Akismet to reduce spam. Learn how your comment data is processed.